Dr. Henry Ji to Participate in Multiple Investment Conferences in September 2019 to Provide Corporate Updates

SAN DIEGO, Sept. 05, 2019 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”), announced today that Dr. Henry Ji, Chairman and CEO, will participate in multiple investment conferences in September 2019. Dr. Ji will provide corporate updates to investors, focusing on the core clinical pipeline progress for Sorrento Therapeutics immuno-oncology and pain programs.